tbuckley/cabot-search huggingface dataset:
Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference
Authors: Signe Foghsgaard, Camilla Andreasen, Louise Vedtofte, Emilie S. Andersen, Emilie Bahne, Charlotte Strandberg, Thora Buhl, Jens J. Holst, Jens A. Svare, Tine D. Clausen, Elisabeth R. Mathiesen, Peter Damm, Lise L. Gluud, Filip K. Knop, Tina Vilsbøll
Journal: Diabetes Care (2016)

Type 2 diabetes increases the risk of nonalcoholic fatty liver disease (NAFLD), which is a potentially reversible condition but is also associated with progressive fibrosis and cirrhosis. Women with prior gestational diabetes mellitus (pGDM) have a higher risk for NAFLD.One hundred women without diabetes who had pGDM (median [interquartile range]: age 38.6 [6.4] years; BMI 31.0 [6.2] kg/m2) and 11 healthy control subjects without NAFLD (age 37.9 [7.8] years; BMI 28.1 [0.8] kg/m2) underwent a 75-g oral glucose tolerance test (OGTT), DXA whole-body scan, and ultrasonic evaluation of hepatic steatosis.Twenty-four (24%) women with pGDM had NAFLD on the basis of the ultrasound scan. None had cirrhosis. Women with NAFLD had a higher BMI (P = 0.0002) and waist circumference (P = 0.0003), increased insulin resistance (P = 0.0004), and delayed suppression of glucagon after the OGTT (P < 0.0001), but NAFLD was not associated with the degree of glucose intolerance (P = 0.2196). Visceral fat mass differed among the three groups, with the NAFLD group having the highest amount of fat and the control subjects the lowest (P = 0.0003). By logistic regression analysis, insulin resistance (P = 0.0057) and waist circumference (P = 0.0109) were independently associated with NAFLD.NAFLD was prevalent in this cohort of relatively young and nonseverely obese women with pGDM who are considered healthy apart from their increased risk for diabetes. Insulin resistance and a larger waist circumference were independently associated with the presence of NAFLD, whereas glucose intolerance was not.
Characteristics, aetiology, antimicrobial resistance and outcomes of bacteraemic cholangitis in patients with solid tumours: A prospective cohort study
Authors: C. Royo-Cebrecos, C. Gudiol, J. García, F. Tubau, J. Laporte, C. Ardanuy, M. Antonio, M. Marin, J.B. Gornals, J. Carratalà
Journal: Journal of Infection (2016)
QOL-19PROSPECTIVE EVALUATION OF CARDIOPULMONARY FITNESS IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING AN ANTI-ANGIOGENIC REGIMEN
Authors: Ashley Ghiaseddin, Miranda West, Whitney Hornsby, Maria Freeman, Eric Lipp, Frances McSherry, James Herndon, Annick Desjardins, Henry Friedman, Lee Jones, Katherine Peters
Journal: Neuro-Oncology (2015)

Anti-angiogenics, such as bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor, are now commonly used in patients with glioblastoma (GBM). With increased use of anti-angiogenics and the importance of maintaining physical function in patients with cancer, including GBM, we sought to evaluate the cardiopulmonary fitness of GBM patients on bevacizumab-containing treatment regimens. In this prospective cohort study, we recruited 18 newly diagnosed GBM patients initiated on a bevacizumab-containing treatment regimen with standard chemoradiation. Cardiopulmonary fitness was assessed using a physician-supervised cardiopulmonary exercise testing with EKG monitoring leads in order to measure relativeVO2 peak, a measure of cardiopulmonary fitness. Study assessments were planned at baseline, after concurrent chemoradiation, after 6 cycles of adjuvant chemotherapy, and after 12 cycles of adjuvant chemotherapy. In this study, 10 of the 18 patients completed baseline testing and at least one follow-up study assessment. Majority of patients were male (70%) and all had gross total resection. KPS ranged from 70-90 with a majority having a KPS = 90 (60%). Mean age at testing was 51.4 years (sd = 13.3 years). Baseline relative VO2 peak was 22.2 mL/kg/min (sd = 6.3 mL/kg/min). After concurrent chemoradiation with bevacizumab, eight patients had testing and relative VO2 peak was 23.1 mL/kg/min (sd = 8.7 mL/kg/min). Five of 10 patients underwent assessment after 6 cycles of adjuvant chemotherapy and there was a non-significant minor increase in relative VO2 peak compared to baseline scores for these 5 patients. One key limitation was maintaining regular testing for patients enrolled, and this was challenging due to disease progression and associated treatment toxicities that precluded use of an anti-angiogenic regimen and/or cardiopulmonary exercise testing. From this study, we can conclude that some GBM patients can undergo cardiopulmonary exercise testing and that, in this small cohort of patients, cardiopulmonary fitness remained relatively intact during treatment regimen with anti-angiogenic therapy.
The Polycistronic miRNA Cluster miR-17-92 Is Over-Expressed in Early Phase Chronic Myeloid Leukemia (CML) CD34+ Cells.
Authors: Letizia Venturini, Karin Battmer, Mirco Castoldi, Beate Schultheis, Andreas Hochhaus, Martina Muckenthaler, Arnold Ganser, Matthias Eder, Michaela Scherr
Journal: Blood (2006)
Antibiotics for the prevention of infection related preterm birth
Authors: Ronald F Lamont
Journal: BMJ (2016)

Stock and Ismail discuss reducing the risk of preterm birth, which is an important cause of neonatal mortality and morbidity.1 But they omit the use of antibiotics to prevent infection related preterm birth. The aetiology of preterm birth is multifactorial, but overwhelming evidence implicates infection or inflammation in up to …
Ineffective Corticosteroid Treatment for Hemolysis Management of Paroxysmal Nocturnal Hemoglobinuria
Authors: Jong Wook Lee, Jun Ho Jang, Je-Hwan Lee, Deog-Yeon Jo, Jin Seok Kim, Yong Park, Sang Kyun Sohn, Jun Sung Park, Chul Won Choi, Joo Seop Chung, Jae Hoon Lee, Jeong A Kim, Jong-Ho Won
Journal: Blood (2014)
Response: Renal dosing of allopurinol results in suboptimal gout care by T Neogi <i>et al</i>
Authors: Pascal Richette, Michael Doherty, Eliseo Pascual, Thomas Bardin
Journal: Annals of the Rheumatic Diseases (2016)

We sincerely appreciate the interest shown by Dr T Neogi⇓ and colleagues1 concerning our 2016 revised European League Against Rheumatism (EULAR) recommendations for the management of gout.2

Dr T Neogi and colleagues raised concern with the ninth item, in which we recommend to adjust the maximum dosage of allopurinol according to the creatinine clearance (CrCl) in order to decrease the risk of severe cutaneous allergic reactions (SCARs).

First, we would like to emphasise that these recommendations were written from a European perspective. In many countries in Europe, regulatory agencies require this adjustment, an important point we took into account for the elaboration of this recommendation. Furthermore, in addition to rheumatologists, the task force included general practitioners, who manage the vast majority of people with gout, patients with gout who are on urate-lowering treatment, and evidence-based medicine (EBM) experts. Therefore, the recommendations reflect perspectives from multiple stakeholders and follow the principles of EBM by examining all types of evidence (patient views, expert opinion and experience, research evidence) in the realisation that each has its strengths and weaknesses, and it is only when …
Improved Prediction of Acute Leukemia Relapse after Allogeneic SCT by Chimerism Analysis of Null Alleles and Indel Polymorphisms with Real-Time Quantitative PCR.
Authors: Antonio Jimenez-Velasco, Manuel Barrios, Jose Roman-Gomez, German Navarro, Ismael Buño, Jose L. Diez-Martin, Antonio Torres, Ana I. Heiniger
Journal: Blood (2004)
Two Cycles of Risk-Adapted Consolidation Leads to a Favorable Long-Term Prognosis in Patients with Acute Promyelocytic Leukemia After Standard AIDA Induction: Results From 141 Patients Treated in the SAL-AIDA-2000 Trial
Authors: Uwe Platzbecker, Ulrich Schuler, Martin Bornhäuser, Michael Kramer, Markus Schaich, Uta Oelschlagel, Brigitte Mohr, Mathias Hänel, Hannes Wandt, Thomas Wagner, Hermann Einsele, Stefan W. Krause, Heinrich Bodenstein, Walter E. Aulitzky, Norbert Schmitz, Anthony D. Ho, Gerhard Ehninger, Christoph Röllig
Journal: Blood (2011)
Blinded Mid-Treatment FDG-PET in Newly Diagnosed Aggressive Non-Hodgkin Lymphoma (NHL): First Results of a Prospective Multicenter Study.
Authors: Bart W. Schot, Josée Zijlstra, Otto S. Hoekstra, Jan Pruim, Gustaaf W. van Imhoff, Wim Sluiter, John M.M. Raemaekers, Wim Oyen, Michel Van Gelder, Olga Eriks, P.C. Huijgens, Edo Vellenga
Journal: Blood (2006)
Respiratory Synctial Virus (RSV) Infection in Hematopoietic Stem Cell Transplant (HCT) Recipients: Risk Factors for Acquisition and Lower Respiratory Tract Disease, and Impact on Mortality.
Authors: Michael J. Boeckh, Ted Gooley, Janet Englund, Jason W. Chien, Stephen W. Crawford, Raleigh Bowden, Corey Lawrence
Journal: Blood (2004)
Association of Industry Sponsorship With Outcomes of Nutrition Studies
Authors: Nicholas Chartres, Alice Fabbri, Lisa A. Bero
Journal: JAMA Internal Medicine (2016)

Food industry sponsorship of nutrition research may bias research reports, systematic reviews, and dietary guidelines.To determine whether food industry sponsorship is associated with effect sizes, statistical significance of results, and conclusions of nutrition studies with findings that are favorable to the sponsor and, secondarily, to determine whether nutrition studies differ in their methodological quality depending on whether they are industry sponsored.OVID MEDLINE, PubMed, Web of Science, and Scopus from inception until October 2015; the reference lists of included reports.Reports that evaluated primary research studies or reviews and that quantitatively compared food industry-sponsored studies with those that had no or other sources of sponsorship.Two reviewers independently extracted data from each report and rated its quality using the ratings of the Oxford Centre for Evidence-Based Medicine, ranging from a highest quality rating of 1 to a lowest of 5.Results (statistical significance and effect size) favorable to the sponsor and conclusions favorable to the sponsor. If data were appropriate for meta-analysis, we used an inverse variance DerSimonian-Laird random-effects model.Of 775 reports reviewed, 12, with quality ratings ranging from 1 to 4, met the inclusion criteria. Two reports, with data that could not be combined, assessed the association of food industry sponsorship and the statistical significance of research results; neither found an association. One report examined effect sizes and found that studies sponsored by the food industry reported significantly smaller harmful effects for the association of soft drink consumption with energy intake and body weight than those not sponsored by the food industry. Eight reports, including 340 studies, assessed the association of industry sponsorship with authors' conclusions. Although industry-sponsored studies were more likely to have favorable conclusions than non-industry-sponsored studies, the difference was not significant (risk ratio, 1.31 [95% CI, 0.99-1.72]). Five reports assessed methodological quality; none found an association with industry sponsorship.Although industry-sponsored studies were more likely to have conclusions favorable to industry than non-industry-sponsored studies, the difference was not significant. There was also insufficient evidence to assess the quantitative effect of industry sponsorship on the results and quality of nutrition research. These findings suggest but do not establish that industry sponsorship of nutrition studies is associated with conclusions that favor the sponsors, and further investigation of differences in study results and quality is needed.
Response to: ‘JAK inhibition in STING-associated interferonopathy’ by Crow<i>et al</i>
Authors: Victoria Tüngler, Nadja König, Claudia Günther, Kerstin Engel, Christoph Fiehn, Martin Smitka, Maja von der Hagen, Reinhard Berner, Min Ae Lee-Kirsch
Journal: Annals of the Rheumatic Diseases (2016)

We appreciate the comments by Crow et al on our report of a gain-of-function mutation in STING in familial chilblain lupus and the effect of the JAK inhibitor tofacitinib.1 In a concurrent study,2 Crow et al reported a marked clinical improvement in three patients with stimulator of interferon genes (STING)-associated vasculopathy3 using the JAK inhibitor ruxolitinib. This was accompanied by an incomplete reduction in the expression of interferon (IFN)-stimulated genes (ISGs) in blood raising the question as to the IFN signature as a read-out of clinical efficacy. This is a very important question that we cannot answer with regard to tofacitinib as we have no long-term experience with this JAK inhibitor in patients with type I interferonopathies. However, we have used ruxolitinib in two patients with Aicardi-Goutieres syndrome (AGS), an inflammatory encephalopathy characterised by chronic type I IFN activation.4 Both patients carried biallelic RNASEH2B mutations and suffered from severe developmental delay. They received no other medications, when treatment with ruxolitinib …
Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures
Authors: Joseph Jacob, Brian J. Bartholmai, Srinivasan Rajagopalan, Maria Kokosi, Arjun Nair, Ronald Karwoski, Simon L.F. Walsh, Athol U. Wells, David M. Hansell
Journal: European Respiratory Journal (2016)

Computer-based computed tomography (CT) analysis can provide objective quantitation of disease in idiopathic pulmonary fibrosis (IPF). A computer algorithm, CALIPER, was compared with conventional CT and pulmonary function measures of disease severity for mortality prediction.CT and pulmonary function variables (forced expiratory volume in 1 s, forced vital capacity, diffusion capacity of the lung for carbon monoxide, transfer coefficient of the lung for carbon monoxide and composite physiologic index (CPI)) of 283 consecutive patients with a multidisciplinary diagnosis of IPF were evaluated against mortality. Visual and CALIPER CT features included total extent of interstitial lung disease, honeycombing, reticular pattern, ground glass opacities and emphysema. In addition, CALIPER scored pulmonary vessel volume (PVV) while traction bronchiectasis and consolidation were only scored visually. A combination of mortality predictors was compared with the Gender, Age, Physiology model.On univariate analyses, all visual and CALIPER-derived interstitial features and functional indices were predictive of mortality to a 0.01 level of significance. On multivariate analysis, visual CT parameters were discarded. Independent predictors of mortality were CPI (hazard ratio (95% CI) 1.05 (1.02-1.07), p<0.001) and two CALIPER parameters: PVV (1.23 (1.08-1.40), p=0.001) and honeycombing (1.18 (1.06-1.32), p=0.002). A three-group staging system derived from this model was powerfully predictive of mortality (2.23 (1.85-2.69), p<0.0001).CALIPER-derived parameters, in particular PVV, are more accurate prognostically than traditional visual CT scores. Quantitative tools such as CALIPER have the potential to improve staging systems in IPF.
The Determination of Sulphur Dioxide in Foods.
Journal: JAMA (1927)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A Comparison of Two Induction Regimens for Older Patients with Acute Lymphoblastic Leukemia: Daunorubicin, Vincristine and Prednisone (DVP) is Worth Considering
Authors: Daniel Landsburg, David Porter, Edward Stadtmauer, Alison Loren, Donald Tsai, Noelle Frey, Steven Goldstein, Elizabeth Hexner, Sunita Dwivedy Nasta, Alexander Perl, Jennifer Davis, Selina Luger
Journal: Blood (2010)
Unusual Aspects of Breast Cancer
Authors: Harold J. Burstein, Scott J. Swanson, Roger L. Christian, Mairin E. McMenamin
Journal: Journal of Clinical Oncology (2001)

Article Tools DIAGNOSIS IN ONCOLOGY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2001.19.9.2571 Journal of Clinical Oncology - published online before print September 21, 2016 PMID: 11331338 Unusual Aspects of Breast Cancer Case 2. Synchronous Bilateral Lung and Breast Cancers Harold J. BursteinxHarold J. BursteinSearch for articles by this author , Scott J. SwansonxScott J. SwansonSearch for articles by this author , Roger L. ChristianxRoger L. ChristianSearch for articles by this author , Mairin E. McMenaminxMairin E. McMenaminSearch for articles by this author Show More Dana-Farber Cancer Institute, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, Copyright © 2001 American Society of Clinical Oncology https://doi.org/10.1200/JCO.2001.19.9.2571 First Page Full Text PDF Figures and Tables © 2001 by American Society of Clinical Oncology
The Natural History of Myeloma Patients Who Relapse Early After High Dose Therapy.
Authors: Nory Holle, Ping Wu, Charlotte Pawlyn, Radovan Saso, Jennifer G. Treleaven, Michael Potter, Mark E Ethell, Bronwen E. Shaw, Walter M Gregory, Sandra Croockewit, Gareth J. Morgan, Faith E. Davies
Journal: Blood (2012)
P0210 : Combined partial splenic embolization (PSE) allows reducing transjugular intrahepatic portosystemic shunt (TIPS) diameter in hypersplenic cirrhotic patients: A pilot study
Authors: D. Regnault, A. Geffray, C. Nicolas, L. D’Alteroche, J. Pucheux, M. Sainz Barriga, P. Bucur, E. Salame, J.-M. Perarnau
Journal: Journal of Hepatology (2015)
A Patient-Derived EZH2 Mutant Induces MDS-like Diseases with Derepressed ABCG2 Expression in Mice
Authors: Kimihito Cojin Kawabata, Daichi Inoue, Jiro Kitaura, Yuka Harada, Susumu Goyama, Hironori Harada, Hiroyuki Aburatani, Toshio Kitamura
Journal: Blood (2015)
Pre-Clinical Studies of a Novel Recombinant Human Granulocyte Colony-Stimulating Factor
Authors: Zhihua Ren, Wenhong Jiang, Zhenwang Jie, Xiaoxiao Liu, Fei Xia, Jie Fan, Keyong Shi, Xinxin Ding, Wei Dai, Yongping Jiang
Journal: Blood (2014)
Considering the role of ecology on individual differentiation
Authors: Tomás Cabeza de Baca, Rafael Antonio Garcia, Michael Anthony Woodley of Menie, Aurelio José Figueredo
Journal: Behavioral and Brain Sciences (2016)

Abstract Our commentary articulates some of the commonalities between Baumeister et al.'s theory of socially differentiated roles and Strategic Differentiation-Integration Effort. We expand upon the target article's position by arguing that differentiating social roles is contextual and driven by varying ecological pressures, producing character displacement not only among individuals within complex societies, but also across social systems and multiple levels of organization.
Outcome and Prognostic Index for Reduced-Intensity Allogeneic Stem Cell Transplantation (RIST) for Elderly Patients with De Novo Acute Myeloid Leukemia (AML): A Study From the AML Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)
Authors: Heiwa Kanamori, Takahiro Fukuda, Shuichi Taniguchi, Masashi Sawa, Tadakazu Kondo, Koichi Miyamura, Naoki Kobayashi, Hikaru Kobayashi, Yasuo Morishima, Makoto Hirokawa, Yoshiko Atsuta, Akiyoshi Takami
Journal: Blood (2012)
Abnormally High Levels of Circulating CD34+CD38−, CD34+CD38+, and CD10+ Hematopoietic Stem and Progenitor Cells in the Peripheral Blood of B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Suggest the Presence of Additional Therapeutic Target Cells.
Authors: Kent W. Christopherson, Laura A. Paganessi, Darilyn R. Rhoades, Hortense M. Dillon, Sefer Gezer, Melissa L. Larson, Henry C. Fung, Stephanie A. Gregory
Journal: Blood (2007)
STEM-01NEURAL STEM CELL-MEDIATED ENZYME/PRODRUG THERAPY FOR NEUROBLASTOMA: TRANSLATION TO THE CLINIC
Authors: Margarita Gutova, Leanne Goldstein, Marianne Metz, Anahit Hovsepyan, Lyudmila Tsurkan, Revathiswari Tirughana, Zesheng Wan, Timothy Synold, Robert Seegar, Clarke Anderson, Philip Potter, Rex Moats, Karen Aboody
Journal: Neuro-Oncology (2015)

Neuroblastoma (NB), a neuroendocrine tumor, is the most common extracranial solid tumor of childhood. 45% of these patients are diagnosed with metastatic high-risk tumors, for which treatment options are limited. Neural stem cells (NSCs), engineered to secrete a modified carboxylesterase (CE) can home to metastatic neuroblastoma tumor foci in multiple organs, and convert the prodrug CPT-11 (Irinotecan; IRN) to the 1000 fold more potent topoisomerase-1 inhibitor SN-38. The goal of our current efficacy and safety/toxicity IND-enabling studies is to identify the optimal dose and schedule of IV administered NSCs adenovirally transduced to secrete a modified human CE (hCE1m6-NSCs), followed by human equivalent doses of IRN. This would ideally provide a tumor selective, more effective and less toxic treatment for children with high-risk NB. We have determined the in vitro IC50 values of 4 human derived neuroblastoma lines to SN-38, IRN only and IRN + hCE1m6-NSC conditioned media. All NB lines were 500-2000 fold more sensitive to hCE1m6-NSC conditioned media + IRN as compared to IRN alone. In vivo clearance of hCE1m6-NSCs through peripheral organs and circulation in naive non-tumor bearing Es1e/SCID mice was within 24h, as detected using PCR analysis. In subcutaneous models of human NB we have quantified NSC tumor distribution and performed pharmacokinetic studies demonstrating tumor-specific conversion of IRN to SN-38. In our metastatic NB mouse models, preliminary results showed that hCE1m6-NSCs in combination with 3 days of IRN (15 mg/kg) had a significant decrease in bioluminescent signal as an indicator of tumor burden, as compared to the IRN only group. Treatment with hCE1m6-NSCs and IRN increased long-term survival of mice bearing CHLA-136 NB tumors. If ongoing IND-enabling studies are successful, we plan to be in phase I studies in pediatric patients with refractory or relapsed high-risk NB by 2018.
Low Transplant-Related Mortality in Patients with Hematologic Malignancies Undergoing Umbilical Cord Blood Transplantation (UCBT) with Thiotepa (TT), Once-Daily Intravenous (IV) Busulfan (BU), Fludarabine (FLU) and Anti-Thymocyte Globulin (ATG).
Authors: Jaime Sanz, William Arcese, Juan C. Hernandez-Boluda, Christelle Ferra, Marta Gonzalez, Carmen Martin, David Serrano, Raul Cordoba, Alessandra Picardi, Carlos Solano, Miguel A. Sanz, Guillermo Sanz
Journal: Blood (2007)
Reply to Jae Heon Kim's Letter to the Editor re: Mauro Gacci, Giovanni Corona, Arcangelo Sebastianelli, et al. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis. Eur Urol 2016;70:788–96
Authors: Mauro Gacci, Linda Vignozzi, Giovanni Corona, Sergio Serni, Mario Maggi
Journal: European Urology (2016)
Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force
Authors: R. Stauder, B. Eichhorst, M.E. Hamaker, K. Kaplanov, V.A. Morrison, A. Österborg, I. Poddubnaya, J.A. Woyach, T. Shanafelt, L. Smolej, L. Ysebaert, V. Goede
Journal: Annals of Oncology (2016)